Cargando…

SOD1 is a synthetic lethal target in PPM1D-mutant leukemia cells

The DNA damage response is critical for maintaining genome integrity and is commonly disrupted in the development of cancer. PPM1D (protein phosphatase, Mg2+/Mn2+ dependent 1D) is a master negative regulator of the response; gain-of-function mutations and amplifications of PPM1D are found across sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Linda, Hsu, Joanne I., Braekeleer, Etienne D., Chen, Chun-Wei, Patel, Tajhal D., Urya, Hidetaka, Guzman, Anna G., Martell, Alejandra G., Waldvogel, Sarah M., Tovy, Ayala, Callen, Elsa, Murdaugh, Rebecca, Richard, Rosemary, Jansen, Sandra, Vissers, Lisenka, de Vries, Bert B.A., Nussenzweig, Andre, Huang, Shixia, Coarfa, Cristian, Anastas, Jamie N., Takahashi, Koichi, Vassiliou, George, Goodell, Margaret A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491179/
https://www.ncbi.nlm.nih.gov/pubmed/37693622
http://dx.doi.org/10.1101/2023.08.31.555634
Descripción
Sumario:The DNA damage response is critical for maintaining genome integrity and is commonly disrupted in the development of cancer. PPM1D (protein phosphatase, Mg2+/Mn2+ dependent 1D) is a master negative regulator of the response; gain-of-function mutations and amplifications of PPM1D are found across several human cancers making it a relevant pharmacologic target. Here, we used CRISPR/Cas9 screening to identify synthetic-lethal dependencies of PPM1D, uncovering superoxide dismutase-1 (SOD1) as a potential target for PPM1D-mutant cells. We revealed a dysregulated redox landscape characterized by elevated levels of reactive oxygen species and a compromised response to oxidative stress in PPM1D-mutant cells. Moreover, we observed marked genomic instability in mutant cells, which is exacerbated upon inhibition of SOD1. Altogether, our results demonstrate the protective role of SOD1 against oxidative stress and DNA damage in PPM1D-mutant leukemia cells and highlight a new potential therapeutic strategy against PPM1D-mutant cancers.